Annovis Bio annovisbio.com


Public list: Pharma Startups (6570) Neuroscience Startups (947)

Annovis Bio (NYSE: ANVS) is a clinical-stage, drug platform company addressing chronic and acute neurodegeneration, such as Alzheimer's disease in Down syndrome (AD-DS), Alzheimer's disease (AD) and Parkinson's disease (PD). Annovis' approach is to develop drugs that normalize the transport of information within and between nerve cells, called axonal transport. Its drug, ANVS-401, restores axonal transport and homeostasis in the brain by inhibiting the synthesis of neurotoxic proteins. Annovis h...Show all

Annovis Bio (NYSE: ANVS) is a clinical-stage, drug platform company addressing chronic and acute neurodegeneration, such as Alzheimer's disease in Down syndrome (AD-DS), Alzheimer's disease (AD) and Parkinson's disease (PD). Annovis' approach is to d...Show all

Company (IPO / Went public)

Phone: 610-727-3913

Fax:

1055 Westlakes Drive
Suite 300
Berwyn, 19312
Pennsylvania, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Annovis Bio $11.9M Jan 29, 2020
Intarcia Therapeutics $1712.2M Mar 12, 2019
Hyperion Therapeutics $206.6M Mar 30, 2015
See all 19 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Annovis Bio Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 10 investors

Competitors

Company Status Description Investors
See all 19 competitors